BIRC5 and cancer: Given that survivin is the fourth most upregulated mRNA in the human cancer transcriptome [140] and its expression has been correlated with increased tumour resistance to a broad range of chemotherapy agents, radiation insensitivity and poor patient prognosis, it has been investigated as target for therapeutic intervention.